News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Memphasys.
RELATED STOCKHEAD STORIES
Health & Biotech
Alive and Kicking: Lumos Diagnostics attracts ‘Twiggy’ Forrest as cornerstone holder in $10m raise
News
Market Highlights: ASX to fall sharply after Wall Street plunges; Nvidia hammered 9.5pc
Health & Biotech
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Alcidion soars as it helps bring UK patient records into digital age
News
Closing Bell: ASX rides high as gold, silver, copper, and iron ore surge; Nuix jumps 25pc
Health & Biotech
ASX Health Stocks: Memphasys’ Felix triumphs over traditional sperm-prepping methods for IVF
News
Closing Bell: Strap on the horns ‘cos it’s five straight on the ASX with Materials a gimme when China talks stimmy
Health & Biotech
ASX Health Stocks: Memphasys tumbles almost 30pc after cow pregnancy trial disappoints
News
Top 10 at 10: Data stock on the rise as Domino’s gets burnt, cattle inseminator shoots blanks
News
In Case You Missed It: Lithium, chocolate and an IVF tech distribution deal
News
Closing Bell: ASX surges late as weak China PMIs smell a lot like pre-stimmy
Health & Biotech
ASX Health Stocks: Memphasys reports 10 new live births in India using its Felix System
Health & Biotech
ASX Health Stocks: Firebrick achieves primary endpoint in Phase 2; Memphasys surges 20pc on Japan deal
News
Top 10 at 10: Lithium Australia hops into bed with big gun Mineral Resources
News
Market Highlights: Wall Street megacaps slip, China’s deflation, and best day to buy Bitcoin
Health & Biotech
